InnoMed PredTox
InnoMed PredTox
InnoMed PredTox is a joint Industry and European Commission collaboration to improve drug safety. The consortium is composed of 14 pharmaceutical companies, three academic institutions and two technology providers.
The goal of InnoMed PredTox is to assess the value of combining results from omics technologies together with the results from more conventional toxicology methods in more informed decision making in preclinical safety evaluation.
| Project | Consortium | Media & Events |
|---|---|---|